Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Agimexpharm Pharmaceutical JSC Net Margin %?
Agimexpharm Pharmaceutical JSCHSTC:AGP 13 Net Margin % is 0.00% as of . 20. GuruFocus rates HSTC:AGP with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 960 Drug Manufacturers companies, Agimexpharm Pharmaceutical JSC ranks worse than 104166.56% on this metric.
The historical rank and industry rank for Agimexpharm Pharmaceutical JSC's Net Margin % or its related term are showing as below:
HSTC:AGP's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56 * Ranked among companies with meaningful Net Margin % only.
Agimexpharm Pharmaceutical JSC (HSTC:AGP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Agimexpharm Pharmaceutical JSC Net Margin % Related Terms
Agimexpharm Pharmaceutical JSC Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agimexpharm Pharmaceutical JSC Net Margin % Chart
Agimexpharm Pharmaceutical JSC Annual Data
Trend
Net Margin %
Agimexpharm Pharmaceutical JSC Semi-Annual Data
Net Margin %
HSTC:AGP vs : Net Margin % Comparison
For the Drug Manufacturers - General subindustry, Agimexpharm Pharmaceutical JSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agimexpharm Pharmaceutical JSC Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Agimexpharm Pharmaceutical JSC's Net Margin % distribution charts can be found below:
* The bar in red indicates where Agimexpharm Pharmaceutical JSC's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. According to the industry distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 960 companies in the Drug Manufacturers industry.
Is Agimexpharm Pharmaceutical JSC's Net Margin % too high?
Agimexpharm Pharmaceutical JSC's current Net Margin % is 0.00%. Based on the distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 960 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Agimexpharm Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Agimexpharm Pharmaceutical JSC's Net Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Agimexpharm Pharmaceutical JSC ranks #999999 out of 960 companies for Net Margin %. This places Agimexpharm Pharmaceutical JSC in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agimexpharm Pharmaceutical JSC's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agimexpharm Pharmaceutical JSC stock overvalued right now?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Agimexpharm Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Agimexpharm Pharmaceutical JSC (HSTC:AGP), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Agimexpharm Pharmaceutical JSC Business Description
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
13GF Score
Get the complete analysis for HSTC:AGP
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:AGP has been successfully added to your 
